Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  6. 8-K Event Other events
  7. EFFECT Other Notice of Effectiveness
  8. 424B5 Offering Prospectus
  9. 8-K Event Material agreement · Other events
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. S-3/A Offering Registration Statement
  12. 10-Q Report Quarterly Report
  13. DEFA14A Proxy Proxy Materials
  14. DEFA14A Proxy Proxy Materials
  15. DEF 14A Proxy Proxy Statement
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. S-3/A Offering Registration Statement
  18. PRE 14A Proxy Proxy Statement (Preliminary)
  19. UPLOAD Other SEC-generated Letter
  20. 8-K Event Other events

Page 16 of 72 · 1,429 filings